An Early Stage Study to Evaluate Oba01 for Injection in Patients With DR5 Positive LA/mNSCLC

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-small Cell Lung Cancer Metastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Oncology, Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
Contact: Study coordinator (Shun Lu) · shunlu@sjtu.edu.cn · 86-21-22200000

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Rochester, United States · Rochester, United States

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Non Small Cell Lung Cancer · Lung Cancer · Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Beverly Hills, United States · Duarte, United States

A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

Non-small Cell Lung Cancer · Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

AB122 Platform Study

Advanced or Metastatic Solid Tumor · Pancreatic Ductal Adenocarcinoma · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1

Aichi, Japan · Chiba, Japan